start portlet menu bar

Visualitzador de contingut web

Display portlet menu
end portlet menu bar

Evaluation of the safety of a new inactivated vaccine against porcine parvovirus and <i>Erysipelothrix rhusiopathiae</i> under field conditions

Inici Coneixement Evaluation of the safety of a new inactivated vaccine against porcine parvovirus and <i>Erysipelothrix rhusiopathiae</i> under field conditions

Evaluation of the safety of a new inactivated vaccine against porcine parvovirus and <i>Erysipelothrix rhusiopathiae</i> under field conditions

The aim of this study was to evaluate the safety of a new inactivated vaccine against Porcine Parvovirus (PPV) and <i>Erysipelothrix rhusiopathiae</i> under field conditions.

Sobre aquest article

Publicat en

ESPHM Congress, 2014

Autors

Noguera, M.; Puig, A.; Simon, M.; Peroxo, E.; Fontseca, M.; Camprodon, A.; March, R.

Resum

No severe or unexpected adverse events attributable to the vaccination with the new vaccine were observed, independently of the target category: nulliparous or multiparous. None of the sows vaccinated with the new vaccine showed abnormal general or local clinical signs from causes attributable to the vaccination. The average rectal temperature increase for all evaluated sows vaccinated did not exceed 1.5ºC. No sow vaccinated with the new vaccine showed abnormal reproductive performance from causes attributable to the vaccination. No differences regarding the safety parameters between both vaccines were observed.

Serveis relacionats

Productes relacionats

Compartir